Nandakumar A, Anantha N, Venugopal T C, Sankaranarayanan R, Thimmasetty K, Dhar M
Coordinating Unit, Kidwai Memorial Institute of Oncology, Bangalore, India.
Int J Cancer. 1995 Mar 3;60(5):593-6. doi: 10.1002/ijc.2910600504.
Survival from cancer reflects the aggressiveness of the disease, the effectiveness of treatment and host factors such as age. While hospital-based survival rates are typically used to evaluate the care provided in a particular hospital, population-based survival reflects the effectiveness of the overall cancer control strategy in the region. Here, we report the survival experience of 1514 breast cancer patients registered by the Bangalore population-based registry during 1982-1989. There have been very few reports on survival from cancer in India, mainly because of poor patient follow-up and inadequate system of registration of death. This has been largely overcome in this study by means of active follow-up through visits of homes of patients. Scrutiny of medical records and matching with death certificates, was also carried out in a small proportion (12%) of cases. Thus, information on vital status (whether dead or alive) as on January 1, 1993 was available for 1334 (88%) subjects and partial follow up data were available for a further 34 (2%). The observed 5 year survival was 42.3% and the corresponding relative survival was 46.8%. The observed survival was 57.4% for localized disease, 45.8% for direct extension, 37% for those with regional node involvement, 14.2% for distant metastasis and 38.3% for those with unstaged disease. The clinical extent of disease and the educational status were independent predictors of survival.
癌症患者的生存率反映了疾病的侵袭性、治疗效果以及年龄等宿主因素。虽然通常使用基于医院的生存率来评估特定医院提供的医疗服务,但基于人群的生存率反映了该地区整体癌症控制策略的有效性。在此,我们报告了1982年至1989年期间由班加罗尔基于人群的登记处登记的1514例乳腺癌患者的生存情况。关于印度癌症患者生存率的报道非常少,主要原因是患者随访不佳以及死亡登记系统不完善。在本研究中,通过主动上门随访,这一问题在很大程度上得到了克服。在一小部分(12%)病例中,还对病历进行了审查并与死亡证明进行了匹配。因此,截至1993年1月1日,有1334名(88%)受试者的生命状态(是否存活)信息可用,另有34名(2%)受试者有部分随访数据。观察到的5年生存率为42.3%,相应的相对生存率为46.8%。局限性疾病的观察生存率为57.4%,直接蔓延为45.8%,区域淋巴结受累为37%,远处转移为14.2%,未分期疾病为38.3%。疾病的临床范围和教育程度是生存的独立预测因素。